A free clinical walkthrough for physicians, APPs, and allied health professionals that covers the components of the Midlife Health Compass™: MMSI scoring system, metabolic and cardiovascular risk integration, and practical implementation in your practice.
Friday, May 15, 2026 · 8:00-9:00 AM PST
Live Webinar with Q&A
Introducing the Midlife Health Compass™
An Evidence-Based Symptom & Risk Assessment for Midlife Women
Most women with clinically significant menopause symptoms never seek care. Of those who do, many report feeling dismissed. The Midlife Health Compass™ addresses both ends of that gap: a structured, validated 32-item instrument that gives patients language for what they're experiencing, and gives clinicians a richer, faster clinical picture at intake.
This webinar walks through the tool's design, scoring methodology, and clinical logic, including 2026 ACC/AHA dyslipidemia guideline integration, prediabetes and T2D risk stratification, and sex-specific cardiovascular risk language.
What You’ll Learn
Overview of the Menopause & Metabolic Symptom Index (MMSI): 32 items, 8 subscales, validated scoring
Vasomotor, somatic, autonomic, sleep, mood, cognitive, urogenital/sexual, and metabolic/CV risk domains
Integration of PREVENT equations, universal Lp(a) screening, and ApoB guidance from the 2026 ACC/AHA guideline
Prediabetes and type 2 diabetes risk logic with sex-specific framing
Absolute and relative contraindications to menopausal hormone therapy, embedded clinical card
How to implement the MHC™ as a pre-visit intake tool or clinical workflow anchor
About Dr. Patil-Sisodia
Dr. Komal Patil-Sisodia is a triple board-certified physician in Internal Medicine, Endocrinology, and Obesity Medicine and a Menopause Society Certified Practitioner.
She founded Eastside Menopause & Metabolism and developed the Midlife Health Compass™ out of direct clinical need to give women the kind of personalized, evidence-based menopause care they deserve.
This is a tool she uses in her own direct specialty practice serving patients in Washington and California.